- by Alison
As COVID-19 vaccines roll out across the world, researchers are hoping it could inject new momentum into the search for safe and effective vaccines against dengue fever. Could new vaccine technologies, including mRNA vaccine platforms, offer fresh hope? It’s now five years since Sanofi Pasteur…
Read more
- by Alison
Sanofi Pasteur’s Dengvaxia was the first dengue vaccine to be licensed. Originally licensed in Mexico in December 2015, it is now licenced in 20 countries, according to the World Health Organization (WHO), for use in people aged 9 and 45 living in dengue-endemic areas. While…
Read more
- by Alison
Professor Duane Gubler is one of the world’s leading experts on dengue vaccines. He has supported the development of all three of today’s leading vaccines: Sanofi’s Dengvaxia, the Takeda dengue vaccine and the NIH (US National Institutes of Health) dengue vaccine, both currently in clinical…
Read more
- by Gary Finnegan
The decision focuses on overseas territories – but climate change could bring mosquito-borne diseases to northern Europe The European Medicines Agency – the EU drug watchdog – has paved the way for the approval of the first vaccine for prevention of dengue. The EMA’s influential…
Read more
- by Alison
Life is full of decisions. But no decision is ever black or white. Each has an upside and a downside. Every health decision – medical treatment, surgery and preventative measure – has its benefits and its risk. We spoke with Professor Tikki Pang (Pangestu), Visiting…
Read more
- by Gary Finnegan
World Immunization Week and vaccine confidence The dengue vaccine scare that erupted last November prompted a fierce political and public reaction in the Philippines – yet another dengue immunization program in a Brazilian state has been unaffected. A leading vaccine confidence expert has drawn contrasts between…
Read more
- by Alison
The dengue fever vaccine pipeline is advancing and as candidates approach clinical trials, we decided to take a closer look at the vaccines that could ease the burden of this disease. The world’s first dengue vaccine, Dengvaxia, was licensed by Sanofi Pasteur in 2015. It…
Read more
- by Gary Finnegan
The unique characteristics of dengue fever mean the dengue vaccine is different to other vaccines, according to an expert from The Philippines Most vaccines are given to infants before they are exposed to a disease-causing virus or bacteria. Dengue is different. Because the disease can…
Read more
- by Gary Finnegan
The impact of a second dengue infection can be amplified due to antibodies produced to fight off an earlier infection. That’s why dengue vaccination may be best for those who have already recovered from the disease. ‘Antibody enhancement’ may sound like technical medical jargon but…
Read more
- by Mauro Abati
During the first half of 2017, the Brazilian state offered 30 cities the second of three doses against dengue. Those who missed out on the first dose were given a second chance to begin the vaccination program. After launching the dengue vaccination program in 2016,…
Read more
